WormBase is an international consortium of biologists and computer scientists from Caltech (USA), Cold Spring Harbour Laboratory (USA), Wellcome Trust Sanger Institute (UK) and the Genome Sequencing Center at Washington University (USA). WormBase is dedicated to providing the research community with accurate, current, accessible information concerning the genetics, genomics and biology of C.elegans and some related nematodes. WormBase can be freely accessed at www.wormbase.org and is also available for download at ftp://ftp.wormbase.org/pub/wormbase/. A new database release is produced every three weeks. The UK WormBase group works closely with the Caenorhabditis Genetics Center (CGC) to curate genetic nomenclature and maintain the C.elegans genetic map. Detailed guidelines are accessible via
http://www.cbs.umn.edu/CGC/Nomenclature/nomenguid.htm Since WS126 (June 2004) all CDSs, transcripts and pseudogenes have been assigned an identifier of the form WBGene00000001. This identifier is unique and remains stable when the gene object is updated. Release WS140 (March 2005) contains 44107 WBGeneIDs of which 24506 are from C.elegans, and 19587 from C.briggsae. The number of CDS objects which have been assigned a CGC approved gene name is 5707. In release WS140 (March 2005) the Variation class was introduced as a more efficient way to handle most of what was in the Allele and Locus classes. The Variation class incorporates the following: Alleles, SNPs (both confirmed and predicted), RFLPs and transposon insertions. Curation of allele data by WormBase biologists is an ongoing project and recent efforts have seen the number of Allele objects in the database increase from about 9000 in WS110 (October 2003) to about 11200 in WS140 (March 2005). Allele information is either captured from scientific journals or submitted directly by researchers using the WormBase submission forms at
http://wormbase.org/db/curate/base WormBase is supported by a grant from the National Human Genomes Reseach Institute at the US National Institute of Health #P41 HG02223 and the British Medical Research Council. CGC is supported by NIH NCRR.